ACAD Financial Facts
Net loss: -71.61MLoss from operations: -72.4M
See Full Income Statement
See Full Balance Sheet
ACADIA Pharmaceuticals (ACAD) Earnings
|
Expand Research on ACAD
| Next EPS Date | 5/1/24 | EPS Growth Rate | +122.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +22.3% | Revenue Growth Rate | +76.1% |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/4/20 |  |
Q320 | -$0.54 | -$0.38 | -$0.16 | $120.6M | $118.82M | = |  | | Details |
8/4/16  |
|
Q216 | -$0.63 | -$0.49 | -$0.14 | $97K | $90K | N/A | | | Details |
| 11/10/14 |
Q314 | -$0.25 | -$0.12 | -$0.13 | N/A | N/A | N/A | | | Details | |
| 5/7/15 |
|
Q115 | -$0.40 | -$0.27 | -$0.13 | $4K | $80K | N/A | | | Details |
| 5/4/22 | |
Q122 | -$0.70 | -$0.60 | -$0.10 | $115.5M | $121.92M | = | | | Details |
| 5/7/20 | |
Q120 | -$0.57 | -$0.48 | -$0.09 | $90.1M | $91.51M | = | | | Details |
| 2/29/16 |
|
Q415 | -$0.45 | -$0.38 | -$0.07 | $17K | $60K | N/A | | | Details |
| 5/1/19 | |
Q119 | -$0.59 | -$0.52 | -$0.07 | $62.96M | $60.69M |  |
| | Details |
